Intellectual Property Partner Tom Campbell published an article in The Global Legal Post titled "How Proposed Drug Pricing and Patent Reform Bills Will Impact US Pharma Innovation." The article discusses how proposed drug pricing and patent reform bills, such as the Inflation Reduction Act, plan to reduce drug costs by allowing Medicare to negotiate prices and limiting patent strategies that prevent generic competition. It also highlights that while these reforms could lower consumer costs, they may also impact innovation by likely reducing private investment in the pharmaceutical sector as a result of changes in patent enforcement and pricing regulations.

Click here to read the full article.